SciBase publishes the Annual report for 2025
SciBase publishes the Annual report for 2025 |
| [27-April-2026] |
STOCKHOLM, April 27, 2026 /PRNewswire/ -- SciBase hereby announces that the Annual report for 2025 is available at the Company's website www.scibase.com. A pdf-version of the annual report is enclosed to this press-release. A printed version of the Annual report will only be distributed to shareholders who actively request a printed copy. For more information, please contact: Michael Colérus, CFO E-mail: michael.colerus@scibase.com Certified Advisor: DNB Carnegie Investment Bank AB (publ) The information was submitted for publication, through the agency of the contact person set out above, at 16.00 CET on April 27, 2026. About SciBase and Nevisense Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs. Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements. The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015 and the company's Certified Adviser is Carnegie Investment Bank AB (publ). Learn more at www.scibase.com. For press releases and financial reports visit: http://investors.scibase.se/en/pressreleases This information was brought to you by Cision http://news.cision.com https://news.cision.com/scibase/r/scibase-publishes-the-annual-report-for-2025,c4340753 The following files are available for download:
| ||||||
Company Codes: ISIN:SE0007045414,Stockholm:SCIB |
View original content:
